ArticleBreast cancer research and treatment2025

Impact of pembrolizumab on ovarian function in young triple-negative breast cancer patients treated with chemo-immunotherapy.

Anne Perdrix et al.PubMed ↗Publisher ↗

No numbers read from the abstract.